Andrew Walsh Annovis Bio, Inc. (ANVS) insider trading activity
Andrew Walsh is Vice President, Finance of Annovis Bio, Inc.. Currently has a direct ownership of 500 shares of ANVS, which is worth approximately $1,330. The most recent transaction as insider was on Jun 16, 2025, when has been sold 500 shares (Common Stock) at a price of $2.9 per share, resulting in proceeds of $1,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
500
n/a
3M change
n/a
12M change
Total Value Held
$1,330
AW
Andrew Walsh
Vice President, Finance
Malvern, PA